Tag: big pharma

City Health Officials Tied to Soros Urge Public to “Get Vaccinated”

A coalition of city public health officials with ties to pharma investor George Soros is urging the public to “get vaccinated.”

In an open letter, the Big Cities Health Coalition accused federal officials of driving down vaccination rates and fueling an increase in dangerous infectious disease outbreaks by making “repeated false claims” about vaccines.

They wrote:

“Vaccines have eradicated devastating diseases and saved millions of lives. They keep classrooms safe and schools open. They allow children to spend time with friends and enjoy their favorite activities. They help parents and caregivers work to support their families.

The letter also addresses recent changes to the Centers for Disease Control and Prevention’s (CDC) recommended vaccine schedule for children and adults, though it does not mention U.S. Health Secretary Robert F. Kennedy Jr. or President Donald Trump by name.

The coalition, which represents 35 U.S. cities and about a fifth of the U.S. population, “has been working together to exchange ideas and address public health threats for more than two decades,” according to CNN, which first reported on the letter Monday.

Participating cities include New York, Los Angeles, Chicago, Boston, Houston, Dallas, Cleveland, Milwaukee and Seattle.

The group’s financial documents reveal support from billionaire financier Soros. Soros has also invested heavily in the pharmaceutical industry, including COVID-19 vaccine makers Pfizer and AstraZeneca, and Gilead Sciences, which produces remdesivir, a controversial antiviral treatment frequently given to COVID-19 patients.

Keep reading

How Vaccine Brain Injuries Were Rebranded and Erased From Memory

I’ve long believed that public relations (propaganda) is one of the most powerful but invisible forces in our society. Again and again, I’ve watched professional PR firms create narratives that most of the country believes, regardless of how much it goes against their self-interests. What’s most remarkable is that despite the exact same tactics being used repeatedly on the public, most people simply can’t see it. When you try to point out exactly how they’re being bamboozled by yet another PR campaign, they often can’t recognize it—instead insisting you’re paranoid or delusional.

That’s why one of my major goals in this publication has been to expose this industry. Once you understand their playbook—having “independent” experts push sculpted language that media outlets then repeat—it becomes very easy to spot, and saves you from falling into the traps most people do. The COVID-19 vaccines, for instance, were facilitated by the largest PR campaign of our lifetime.

One of the least appreciated consequences of this industry is that many of our cultural beliefs ultimately originate from PR campaigns. This explains why so many widely believed things are “wrong”—if a belief were actually true, it wouldn’t require a massive PR investment to instill in society. Due to PR’s power, the viewpoints it instills tend to crowd out other cultural beliefs.

In this article, we’ll take a deeper look at what’s behind one of those implanted beliefs: “vaccines don’t cause autism.”

Keep reading

FDA Stayed Silent As Internal Reports About Potential Tylenol Risks Piled Up

The Food and Drug Administration (FDA) defied the advice of its own drug safety experts to warn pregnant women about Tylenol for nearly a decade, internal reports and presentations obtained by the Daily Caller News Foundation reveal.

FDA rank-and-file scientists repeatedly recommended the agency release information about Tylenol in pregnancy across three scientific reviews conducted in 2016, 2019, 2022 and two memos, one from the FDA’s maternal health division in 2016 and one from the FDA’s urological health division in 2017.

The scientific literature posits many plausible drivers of autism, the most well-established of which are genetic, and the FDA drug safety experts acknowledged that the research linking the condition to Tylenol is far from ironclad.

Still, as alarm bells rang within FDA headquarters and the boardrooms of Tylenol’s manufacturers, pregnant women heard nothing from either the government or the manufacturers about the potential risks until the September announcement by President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr.

FDA leadership declined to update its webpage about over-the-counter painkillers in pregnancy, repeatedly falling back on language first issued in January 2015. But that statement simply acknowledged that “FDA is aware of concerns” about Tylenol and attention deficit hyperactivity disorder (ADHD), citing just one scientific paper.

At the urging of Trump and Kennedy, FDA finally released a nuanced statement in September cautioning pregnant women about Tylenol while acknowledging that aspirin, ibuprofen and high fevers all pose their own risks. That move was first recommended by an FDA drug safety expert nine years earlier.

The DCNF obtained the FDA documents from the law firm Keller Postman LLC, which brought a class action lawsuit against Tylenol maker Kenvue, a legally independent spinoff of Johnson & Johnson. The personal injury law firm, which often brings class action lawsuits, obtained the documents from FDA via the Freedom of Information Act.

Tylenol, a brand name for acetaminophen, first received FDA approval in 1955 before modern drug laws tightened clinical trial requirements in 1962.

Some experts argue that neurological damage occurs due to a toxic byproduct of acetaminophen called NAPQI. Babies and children with autism may struggle to metabolize the drug, resulting in higher levels of NAPQI, which kills cells.

Keep reading

The DARK UNDERBELLY of Weight Loss ‘Miracle’ Drugs

Now, first, let me get one thing outta the way. No, I’ve never really struggled with weight issues. I do have my issues (definitely some screws loose), but poor physical health has never been one of them.

Of course, I’m relatively young.

So what I’m saying is, I certainly cannot relate to people who are constantly overweight despite their best efforts, let alone somebody who is bordering on morbidly obese.

I’ve always had a fast metabolism, and for the most part, I’ve always been active, competitive in sports throughout high school and college. But I’ve also been lucky. Still, I continuously prioritize whole, clean eating when I can, getting out in nature, and regularly doing other things that maybe those darn tree-huggers were right about all along…

Okay. Now that that’s outta the way…

Have you noticed that many people who have hopped on the ‘fat shot’ were also highly supportive of the COVID injections at some point?

Although many of them – even those who were giddy to get jabbed – have fallen quiet about the “mmRNA” in recent times, perhaps realizing they were duped, that hasn’t stopped them from buying into the next big thing, in this case: Big Pharma’s panacea.

It’s good for diabetes! It’s good for weight loss! It’s good for your heart! It’s going to make you live foreeeeeever!!

Keep reading

Popular hair-loss pill linked to depression and suicide

A new analysis by a public health expert at the Hebrew University of Jerusalem has found that finasteride, a widely used treatment for hair loss, has been associated with depression and suicide for more than twenty years. Despite these long-standing concerns, neither regulators nor the drug’s manufacturer took meaningful action. Drawing on adverse event reports and health records from several countries, the review identifies a consistent pattern of psychiatric side effects linked to the drug. Even with growing evidence, both Merck and the FDA failed to launch necessary safety investigations. The author is now urging major reforms to the way medications are approved and monitored for long-term risks.

For more than two decades, finasteride has been prescribed to millions of men seeking to slow or reverse hair loss. Behind its cosmetic appeal, however, evidence has continued to emerge suggesting serious mental health consequences, including depression, anxiety, and in some cases, suicide.

Prof. Mayer Brezis of the Hebrew University of Jerusalem argues that both the medical community and regulators have repeatedly failed to protect the public by overlooking signs of psychiatric harm associated with the drug.

His review analyzed data from eight large studies published between 2017 and 2023. The findings show a clear trend: people who used finasteride were far more likely to experience mood disorders and suicidal thoughts than those who did not. This pattern appeared consistently across various national databases, including the FDA’s adverse event system and healthcare records from Sweden, Canada, and Israel.

“The evidence is no longer anecdotal,” said Prof. Brezis, a professor emeritus of medicine and public health. “We now see consistent patterns across diverse populations. And the consequences may have been tragic.”

The report estimates that hundreds of thousands of users may have suffered from finasteride-related depression, and that hundreds — possibly more — may have died by suicide. Originally approved by the FDA in 1997 for male pattern baldness, the drug has remained popular for its perceived safety and effectiveness, particularly among younger men. Critics say, however, that its risks were downplayed or ignored.

Keep reading

President Trump Announces Major Deal with Drugmaker AstraZeneca, Including $50 BILLION Investment

President Trump on Friday announced another deal with UK-based pharmaceutical company AstraZeneca to lower drug costs for Americans on Medicaid. 

The drug manufacturer will now sell prescription drugs to patients at Most Favored Nations prices through TrumpRx.gov.

This comes after the President struck a deal with Pfizer to also provide Americans with heavily discounted prescription drugs at most-favored-nation prices.

Trump made the announcement on AstraZeneca in the Oval Office on Friday, where he touted his efforts to lower drug costs during his first term and announced Most Favored Nations pricing from “the largest pharmaceutical manufacturer in the United Kingdom.”

“I had it going very well in my first term, but we were interrupted by rigged elections, so I was unable to carry it forward,” the President noted.

Trump also highlighted AstraZeneca’s plans to build a new plant in Charlottesville, Virginia, where they broke ground on Thursday, investing $50 billion in U.S. manufactuting, he said. “It’s going to have 3,600 jobs just to begin with, and that’s going to be a fantastic plant,” Trump said.

Trump delivered remarks on the new deal and AstraZeneca’s manufacturing plans in America for nearly seven minutes before taking questions from the press. AstraZeneca CEO Pascal Soriot, Health and Human Services Secretary Robert F. Kennedy Jr, CMS Administrator, Mehmet Oz, FDA commissioner Marty McCary, and Virginia Governor Glenn Youngkin joined the President and delivered remarks.

Keep reading

Self-Monitoring Blood Glucose Meters Recalled Due to Potentially Defective Displays: FDA

Florida-based Trividia Health Inc. is recalling a limited number of blood glucose meters because of potentially defective liquid-crystal displays that could affect product performance, the company said in an Oct. 7 statement published by the Food and Drug Administration.

The recall applies to Trividia’s True Metrix self-monitoring glucose meters that are co-branded under the Good Neighbor Pharmacy brand. The affected items belong to lot number KD0746, printed on the side of the product box. They were manufactured on Sept. 4 and sold between Sept. 8 and 16 across the United States.

“It is possible that the LCD display for the affected products may show partial or missing numerical segments or characters or show ghosting (fading) of numerical segments or characters,” the company said. “As a result, it is possible that users could misinterpret a test result or experience a delay in obtaining test results. For users with low glucose (hypoglycemia), this could result in a delay in treatment or therapy decisions.”

According to Trividia, it has so far not received any reports of people suffering injuries as a result of using the recalled products.

The company said it was sending notifications to customers, including pharmacies, to inform them of the issue.

“If you have an affected Product, the Trividia Health Customer Care Department will help with return and replacement information,” it said.

Keep reading

New ‘unusual’ side effect of weight-loss drugs becoming more common, research suggests

A new “unusual” side effect of weight-loss drugs is becoming more common, research has suggested.

Weight-loss drugs such as Ozempic and Wegovy have soared in popularity. About one in eight U.S. adults said they’ve taken a GLP-1 drug, used to treat type 2 diabetes and obesity, according to a Kaiser Family Foundation poll published in May 2024.

But like with any other drugs, there are side effects, including a newly found one that could interfere with medical imaging.

Researchers from ​​Alliance Medical, a European imaging service provider, reviewed oncologic FDG PET-CT scans in patients taking GLP-1 drugs.

With an FDG PET scan, a patient gets an IV injection of a radiotracer called fluorodeoxyglucose. Diseased cells in the patient’s body absorb more of the radiotracer than healthy ones do, and the PET scanner detects these “hot spots”, according to the Cleveland Clinic. Healthcare providers may perform a PET scan and a CT scan, which uses X-rays, at the same time to produce more accurate 3D images.

Alliance Medical researchers found several abnormal patterns of FDG uptake in patients taking GLP-1 drugs, according to a September presentation at the Annual Congress of the European Association of Nuclear Medicine. These abnormal patterns could be misinterpreted by doctors if a patient’s medication history is not considered.

“We noticed unusual uptake in one of our patients on a GLP-1 agonist, which prompted a wider review across our network,” lead author Dr. Peter Strouhal, Medical Director at Alliance Medical, said in a statement published by the American Association for the Advancement of Science.

Keep reading

Former FDA Vaccine Chief Peter Marks Joins Pharmaceutical Company

Dr. Peter Marks, who formerly led the Food and Drug Administration’s oversight of vaccines, has joined the pharmaceutical firm Eli Lilly, the company told The Epoch Times on Oct. 7.

“Lilly continually evaluates breakthrough science which could benefit patients. Peter’s expertise strengthens our abilities across multiple areas, both in our existing portfolio and in our work in emerging areas,” a spokesperson for the company told The Epoch Times via email.

Marks is the senior vice president of molecule discovery for Lilly, and the head of its infectious disease unit.

Lilly does not currently make any vaccines for the U.S. market.

Marks, who has a medical degree and a graduate degree in cell and molecular biology, was director of the FDA’s Center for Biologics Evaluation and Research, which oversees vaccines, for years before resigning in April. Marks cited disagreements with Health Secretary Robert F. Kennedy Jr.

Marks sped up the first COVID-19 vaccine approval because he wanted to enable vaccine mandates and have more people vaccinated, according to internal documents, prompting two other FDA vaccine officials to resign. Marks has said the officials were not moving fast enough in light of the pandemic situation.

Keep reading

Aluminium in Vaccines Is Harmful

It has been surprisingly difficult to get an answer to a simple and highly relevant question: Is aluminium in vaccines harmful? After having studied the best evidence we have, the randomised trials, in great detail, I conclude that the answer is yes. 

Like lead, aluminium is a highly neurotoxic metal. We will therefore expect vaccines containing aluminium adjuvants to cause neurological harms if the aluminium enters the nervous system in neurotoxic amounts. 

The aluminium in the adjuvant is important for eliciting a strong immune response in non-live vaccines and their efficacy is related to their toxicity at the injection site.1-3 Immune-reactive cells engulf particles of aluminium adjuvant and distribute their load throughout the body, including to the brain, where they are killed, releasing their contents into the surrounding brain tissue where they can produce an inflammatory response.

The precise mechanism of action is not so important, but the data we have on the harms are, and they have been systematically distorted. 

False Information from the European Medicines Agency (EMA)

In October 2016, my research group complained to the European Ombudsman about the EMA’s mishandling of their investigation into the suspected serious neurological harms of the HPV vaccines.4 In his reply to the Ombudsman, EMA’s Executive Director Guido Rasi stated that the aluminium adjuvants are safe; that their use has been established for several decades; and that the substances are defined in the European Pharmacopoeia.5,6 

Rasi gave the impression that the aluminium adjuvants in the HPV vaccines are similar to those used since 1926. However, the adjuvant in Gardasil, Merck’s vaccine, is amorphous aluminium hydroxyphosphate sulfate, ‎AlHO9PS-3 (AAHS), which has other properties than aluminium hydroxide, the substance Rasi mentioned. Moreover, its properties are not defined in the pharmacopoeia. AAHS has a confidential formula; its properties are variable from batch to batch and even within batches. The harms caused by the adjuvant are therefore likely to vary. When we investigated whether the safety of AAHS has ever been tested in comparison with an inert substance in humans, we were unable to find any evidence of this. 

Rasi mentioned that the assessment of the evidence for the safety of the adjuvants had been performed over many years by the EMA and other health authorities, such as the European Food Safety Authority, the FDA, and the WHO. 

Keep reading